Previous Article | Next Article ![]()
Molecular and Cellular Biology, October 1999, p. 6690-6698, Vol. 19, No. 10
Urologic Research Laboratory, USC/Norris
Comprehensive Cancer Center, University of Southern California
School of Medicine, Los Angeles, California 90089-9181
Received 4 March 1999/Returned for modification 13 April
1999/Accepted 7 July 1999
De novo methylation of CpG islands within the promoters of
eukaryotic genes is often associated with their transcriptional repression, yet the methylation of CpG islands located downstream of
promoters does not block transcription. We investigated the kinetics of
mRNA induction, demethylation, and remethylation of the p16
promoter and second-exon CpG islands in T24 cells after 5-aza-2'-deoxycytidine (5-Aza-CdR) treatment to explore the
relationship between CpG island methylation and gene transcription. The
rates of remethylation of both CpG islands were associated with time but not with the rate of cell division, and remethylation of the p16 exon 2 CpG island occurred at a higher rate than that
of the p16 promoter. We also examined the relationship
between the remethylation of coding sequence CpG islands and gene
transcription. The kinetics of remethylation of the p16
exon 2, PAX-6 exon 5, c-ABL exon 11, and
MYF-3 exon 3 loci were examined following 5-Aza-CdR
treatment because these genes contain exonic CpG islands which are
hypermethylated in T24 cells. Remethylation occurred most rapidly in
the p16, PAX-6, and c-ABL genes,
shown to be transcribed prior to drug treatment. These regions also
exhibited higher levels of remethylation in single-cell clones and
subclones derived from 5-Aza-CdR-treated T24 cells. Our data suggest
that de novo methylation is not restricted to the S phase of the cell
cycle and that transcription through CpG islands does not inhibit their remethylation.
0270-7306/99/$04.00+0
Copyright © 1999, American Society for Microbiology. All rights reserved.
Roles of Cell Division and Gene Transcription
in the Methylation of CpG Islands
*
Corresponding author. Mailing address: Urologic
Research Laboratory, USC/Norris Comprehensive Cancer Center, University
of Southern California School of Medicine, 1441 Eastlake Ave., Rm. 8302L, Los Angeles, CA 90089-9181. Phone: (323) 865-0816. Fax: (323)
865-0102. E-mail: jones_p{at}froggy.hsc.usc.edu.
This article has been cited by other articles:
| J. Bacteriol. | J. Virol. | Eukaryot. Cell |
|---|
| Microbiol. Mol. Biol. Rev. | Clin. Vaccine Immunol. | All ASM Journals |
|---|